A Few Investment Ideas from Fairfax's 13-F
Fairfax's most recent portfolio highlights several of our 5-star stocks.
By Chris Blumas | Stock Analyst
It was a busy first quarter for the team at Hamblin Watsa Investment Counsel, the wholly owned investment management subsidiary of Fairfax Financial (FFH), a recent addition to the Ultimate Stock-Pickers' Investment Manager Roster (which we had highlighted back in April for its relatively large purchases of U.S. equities in the fourth quarter of last year). Unlike the majority of the other insurance firms on our list, which we talked about in recent articles dedicated to Berkshire Hathaway (BRK.A) (BRK.B), Alleghany (Y), and Markel (MKL), Fairfax was actively buying and selling securities during the quarter. The firm's biggest moves involved two beaten-down financial firms, which although not currently trading at prices we'd consider buying them, were deep 5-star names during the first quarter. A much closer look at Fairfax's actions sheds some additional light on how the firm continues to outpace the market and helps us produce a few more stock ideas our analysts believe are worth buying right now.
Fairfax Continues to Outperform
In a three-month period that saw the S&P 500 Index (SPX) decline by nearly 12%, Fairfax's actively managed U.S. equity portfolio declined just 7% to $2.8 billion. (Our total portfolio figures for Fairfax exclude the firm's controlling stake in OdysseyRe (ORH), which, while worth $1.6 billion at end of the first quarter, remains a fairly static position within the portfolio and, as such, skews the composition of the firm's more actively managed investments.)
The Morningstar Ultimate Stock-Pickers Team does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.